Doximity, Inc. (NASDAQ:DOCS) Director Sells $1,152,400.00 in Stock

Doximity, Inc. (NASDAQ:DOCS) Director Timothy S. Cabral sold 20,000 shares of the business’s stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now directly owns 6,360 shares in the company, valued at approximately $366,463.20. The trade was a 75.87 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Doximity Stock Performance

NASDAQ DOCS opened at $58.58 on Friday. Doximity, Inc. has a one year low of $22.96 and a one year high of $61.75. The company has a 50-day simple moving average of $55.09 and a 200-day simple moving average of $45.31. The firm has a market capitalization of $10.94 billion, a PE ratio of 67.33, a price-to-earnings-growth ratio of 4.68 and a beta of 1.39.

Doximity (NASDAQ:DOCS) last posted its earnings results on Thursday, November 7th. The company reported $0.24 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.02). The firm had revenue of $136.83 million for the quarter, compared to analyst estimates of $127.05 million. Doximity had a net margin of 33.69% and a return on equity of 19.79%. During the same period in the previous year, the firm earned $0.18 earnings per share. Equities analysts forecast that Doximity, Inc. will post 0.88 earnings per share for the current year.

Institutional Trading of Doximity

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Global Retirement Partners LLC raised its position in shares of Doximity by 468.1% during the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock worth $29,000 after buying an additional 440 shares in the last quarter. UMB Bank n.a. raised its position in shares of Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after buying an additional 235 shares in the last quarter. Farther Finance Advisors LLC raised its holdings in shares of Doximity by 324.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after purchasing an additional 603 shares in the last quarter. Morse Asset Management Inc bought a new stake in shares of Doximity in the 3rd quarter worth approximately $46,000. Finally, GAMMA Investing LLC raised its holdings in shares of Doximity by 40.1% in the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after purchasing an additional 412 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have commented on DOCS shares. Barclays boosted their price target on shares of Doximity from $52.00 to $75.00 and gave the stock an “overweight” rating in a research note on Monday, November 11th. Wells Fargo & Company boosted their target price on shares of Doximity from $41.00 to $43.00 and gave the stock an “equal weight” rating in a research note on Monday, January 13th. Bank of America boosted their target price on shares of Doximity from $54.00 to $57.00 and gave the stock a “neutral” rating in a research note on Monday, January 6th. Morgan Stanley upgraded shares of Doximity from an “underweight” rating to an “equal weight” rating and boosted their target price for the stock from $33.00 to $53.00 in a research note on Thursday, November 14th. Finally, Stephens began coverage on shares of Doximity in a research note on Friday, December 20th. They set an “equal weight” rating and a $55.00 target price for the company. Thirteen investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $53.12.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.